UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 362

Sortiert nach

Bellmunt risk score as a survival predictor in patients with metastatic castration-resistant prostate cancer

The Prostate, 2024-09, Vol.84 (12), p.1119-1127

2024

Volltextzugriff (PDF)

Real-world data on the prevalence of BRCA1/2 and HRR gene mutations in patients with primary and metastatic castration resistant prostate cancer

World journal of urology, 2024-08, Vol.42 (1), p.491

2024

Volltextzugriff (PDF)

Key learnings from concordant systematic biopsies in prostate‐specific membrane antigen positron emission tomography/computed tomography‐guided prostate biopsies: Enhancing targeting accuracy

The Prostate, 2024-06, Vol.84 (8), p.772-779

2024

Volltextzugriff (PDF)

The relevance of circRNAs in serum of patients undergoing prostate biopsy

International journal of urology, 2024-05, Vol.31 (5), p.578-580

2024

Volltextzugriff (PDF)

Emotion‐centered versus fact‐centered medical information to alleviate pain and anxiety in prostate biopsy: A randomized trial

The Prostate, 2024-03, Vol.84 (4), p.389-394

2024

Volltextzugriff (PDF)

Expression of the microtubule-associated protein 2 (MAP2) as a potential independent prognostic marker in prostate cancer

Journal of cancer research and clinical oncology, 2024-02, Vol.150 (2), p.76-76, Article 76

2024

Volltextzugriff (PDF)

Feasibility of Monitoring Response to Metastatic Prostate Cancer Treatment with a Methylation-Based Circulating Tumor DNA Approach

Cancers, 2024-01, Vol.16 (3), p.482

2024

Volltextzugriff (PDF)

Inflammatory fibroid polyp of the renal pelvis: first report at an extra-gastrointestinal site with molecular confirmation

Virchows Archiv : an international journal of pathology, 2023-10, Vol.483 (4), p.535-539

2023

Volltextzugriff (PDF)

Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance

Clinical cancer research, 2023-04, Vol.29 (8), p.1496-1505

2023

Volltextzugriff (PDF)

LERA—an interactive platform for synoptical representations of multiple text witnesses

Digital Scholarship in the Humanities, 2023-04, Vol.38 (1), p.330-346

2023

Volltextzugriff (PDF)

Early C-reactive protein kinetics predicts immunotherapy response in non-small cell lung cancer in the phase III OAK trial

JNCI cancer spectrum, 2023-03, Vol.7 (2)

2023

Volltextzugriff (PDF)

Identification of F-Box/SPRY Domain-Containing Protein 1 (FBXO45) as a Prognostic Biomarker for TMPRSS2-ERG-Positive Primary Prostate Cancers

Cancers, 2023-03, Vol.15 (6), p.1890

2023

Volltextzugriff (PDF)

Subcutaneous rituximab in patients with diffuse large B cell lymphoma and follicular lymphoma: Final results of the non‐interventional study MabSCale

Cancer medicine (Malden, MA), 2023-02, Vol.12 (3), p.2739-2751

2023

Volltextzugriff (PDF)

Omitting routine cystography after RARP: Analysis of complications and readmission rates in suprapubic and transurethral drained patients

International journal of urology, 2023-02, Vol.30 (2), p.211-218

2023

Volltextzugriff (PDF)

CDCP1 expression is frequently increased in aggressive urothelial carcinoma and promotes urothelial tumor progression

Scientific reports, 2023-01, Vol.13 (1), p.73-73, Article 73

2023

Volltextzugriff (PDF)

Pretreatment albumin is a prognostic and predictive biomarker for response to atezolizumab across solid tumors

Clinical & translational immunology, 2023-01, Vol.12 (11), p.e1472-e1472

2023

Volltextzugriff (PDF)